Showing results (601-610 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|January 5, 2024
Population Pharmacokinetics of the Novel Adenosine A2A Antagonist/Inverse Agonist KW-6356 and Its Active Metabolite Following Single and Multiple Oral Administration in Healthy Individuals and Patients with Parkinson's DiseaseTomonori Tayama, Hiroki Okada, Kotoko Ogawa, et al.
Clinical Pharmacology in Drug Development|December 18, 2023
Safety, Tolerability, and Pharmacokinetics of a Novel Oral Phosphodiesterase 4 Inhibitor, ME3183: First-in-Human Phase 1 StudySeiji Kato, Naoki Cho, Tomokazu Koresawa, et al.
Clinical Pharmacology in Drug Development|February 5, 2024
Results from a Phase 1 Study Assessing the Pharmacokinetics of the Aldosterone Synthase Inhibitor Baxdrostat in Participants with Varying Degrees of Renal FunctionMason W Freeman, Yuan-Di Halvorsen, Mary Bond, et al.
Clinical Pharmacology in Drug Development|January 29, 2024
Safety and Pharmacokinetics of Quizartinib Combination Therapy With Standard Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results from Two Phase 1 Trials in Japan and ChinaJunyuan Qi, Ilseung Choi, Shuichi Ota, et al.
Clinical Pharmacology in Drug Development|January 9, 2024
Comparability of Elezanumab Safety, Tolerability, and Pharmacokinetics in Healthy Japanese, Chinese, and White ParticipantsHari V Kalluri, Matthew R Rosebraugh, Nils Boehm, et al.
Clinical Pharmacology in Drug Development|January 10, 2024
Evaluation of Acarbose Bioequivalence in Healthy Chinese Populations Using Novel Pharmacodynamic End PointsLinling Que, Zhenzhong Qian, Xuemei Xiang, et al.
Clinical Pharmacology in Drug Development|March 25, 2024
Evaluation of Bioequivalence for Avapritinib Tablets in Chinese Participants Under Fasting Conditions Using a Reference-Scaled Average Bioequivalence MethodZenglian Yue, Yin Wang, Zeng Li, et al.
Clinical Pharmacology in Drug Development|March 22, 2024
Clinical Pharmacology of GP40321 (Insulin Glulisine Biosimilar): Pharmacokinetic and Pharmacodynamic Comparability in a Hyperinsulinemic-Euglycemic Clamp ProcedureEkaterina Koksharova, Roman Drai, Sergei Noskov, et al.
Clinical Pharmacology in Drug Development|March 12, 2024
Pharmacokinetic and Safety Comparison of Fixed-Dose Combination of Cilostazol/Rosuvastatin (200 + 20 mg) Versus Concurrent Administration of the Separate Components in Healthy AdultsJae Hoon Kim, Jang Hee Hong, Jin-Gyu Jung, et al.
Clinical Pharmacology in Drug Development|September 20, 2024
Safety, Tolerability, and Pharmacokinetic Profile of the Low-Impact Ampakine CX1739 in Young Healthy VolunteersDaniel P Radin, Rok Cerne, Jeffrey M Witkin, et al.
Pageof 136